Axsome Therapeutics Inc
Change company Symbol lookup
Select an option...
AXSM Axsome Therapeutics Inc
DVRNF Deveron Corp
INTC Intel Corp
SWZ Swiss Helvetia Fund Inc
BALL Ball Corp
KIIIW Kismet Acquisition Three Equity Warrant Exp 30 June 2026 *W EXP 06/30/2026
SG Sweetgreen Inc
MAXN Maxeon Solar Technologies Ltd
PARAP Paramount Global
INT World Fuel Services Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major depressive disorder (MDD), Alzheimer's disease agitation (AD agitation), and smoking cessation. AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine. AXS-12 is an investigational medicine in development for the treatment of narcolepsy. The Company also provides Sunosi, which is dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients.

Closing Price
$40.64
Day's Change
2.34 (6.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
40.72
Day's Low
37.19
Volume
(Light)
Volume:
1,537,312

10-day average volume:
3,749,355
1,537,312
  • Prev Close
    38.30
  • Today's Open
    38.08
  • Day's Range
    37.19-40.72
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    4:00p ET 07/01/22
  • Last (size)
    5
  • 52-Wk Range
    19.38 - 68.74
    LowHigh
  • (07/01/21 - 08/19/21)
    109.70%
  • 116.0%
  • Market Cap
    1.6B
  • Shares Outstanding
    38.9M
  • -3.72
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.1
  • 48.45
  • (% of float 06/15/22)
    16.93

Latest News

July 03, 2022
11:22 am ET
Newsfile
July 02, 2022
12:00 pm ET
Globe Newswire
July 01, 2022
11:30 am ET
Accesswire
11:20 am ET
Globe Newswire
11:00 am ET
Globe Newswire
5:45 am ET
PR Newswire
June 30, 2022
8:03 pm ET
Accesswire
7:30 pm ET
PR Newswire
12:11 pm ET
Accesswire
11:15 am ET
Accesswire
9:31 am ET
PR Newswire
5:45 am ET
PR Newswire
June 29, 2022
9:51 pm ET
Accesswire
9:00 pm ET
Globe Newswire
6:40 pm ET
Accesswire
5:56 pm ET
PR Newswire
4:49 pm ET
Newsfile
3:23 pm ET
Globe Newswire
1:30 pm ET
Accesswire
1:01 pm ET
Accesswire
12:04 pm ET
PR Newswire
10:30 am ET
PR Newswire
June 28, 2022
1:45 pm ET
Accesswire
1:00 pm ET
Globe Newswire
12:33 pm ET
Accesswire
12:00 pm ET
Globe Newswire
9:59 am ET
Newsfile
8:30 am ET
PR Newswire
7:00 am ET
Globe Newswire
5:45 am ET
PR Newswire
June 27, 2022
9:24 pm ET
Newsfile
7:56 pm ET
PR Newswire
4:15 pm ET
PR Newswire
3:50 pm ET
Accesswire
3:15 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.